Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

Clinical trial NCT06828588 · RECRUITING

Trial details

NCT number: NCT06828588
Sponsor: Vanderbilt-Ingram Cancer Center
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Locally Advanced Cancer Metastatic Cancer HER2 HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma HER 2 Low-expressing Breast Cancer

Start date: 2026-04-16
Primary completion: 2027-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.